Quidel Corp., based in San Diego, announced it closed May 27 on the previously announced acquisition of Raritan-based Ortho Clinical Diagnostics Holdings PLC. The deal — which would create a new ...

• Fourth quarter Core revenue grew 3.5% to $518.9 million, or 4.3% in constant currency and 8.0% excluding CoV-2 assay sales • Fiscal year Core revenue grew 16.1% to $2.01 billion, or 14.6% in ...

RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...

Ortho Clinical Diagnostics (OCDX) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.26 per share a year ago.

Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry (AACC) ...

Welcome to the Ortho Clinical Diagnostics first quarter 2022 earnings conference call and Webcast. [Operator instructions] Please note this conference is being recorded. An audio replay of the ...

(Reuters) - Private equity firm Carlyle Group LP is exploring a sale or initial public offering of Ortho-Clinical Diagnostics Inc, a U.S. diagnostics company that could be valued at more than $7 ...

Wall Street's main indexes rose for a third straight session on Thursday after early data suggested that the Omicron variant of the coronavirus was less severe than feared, lifting the mood ahead of ...

Quidel Corp. reported a definitive agreement to acquire Ortho Clinical Diagnostics Holdings plc in a nearly $6 billion deal expected to close in the first half of 2022. The $24.68 per share offered by ...